Yasuhiro Kaneda

Summary

Affiliation: University of Tokyo
Country: Japan

Publications

  1. ncbi [The Schizophrenia Cognition Rating Scale Japanese version (SCoRS-J) as a co-primary measure assessing cognitive function in schizophrenia]
    Yasuhiro Kaneda
    Department of Psychiatry, Iwaki Clinic, Tokushima, Japan
    Nihon Shinkei Seishin Yakurigaku Zasshi 31:259-62. 2011
  2. ncbi Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment
    Yasuhiro Kaneda
    Department of Psychiatry, Iwaki Clinic, Anan, Tokushima, Japan
    Psychiatry Res 178:57-62. 2010
  3. ncbi Verbal working memory and functional outcome in patients with unipolar major depressive disorder
    Yasuhiro Kaneda
    Department of Psychiatry, Iwaki Clinic, Tokushima, Japan
    World J Biol Psychiatry 10:591-4. 2009
  4. ncbi Verbal working memory impairment in patients with current episode of unipolar major depressive disorder and in remission
    Yasuhiro Kaneda
    Department of Psychiatry, Iwaki Clinic, 11 1 Kamimizuta, Tokushima, Japan
    Clin Neuropharmacol 32:346-7. 2009
  5. ncbi Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function
    Yasuhiro Kaneda
    Department of Psychiatry, Iwaki Clinic, 11 1 Kamimizuta, Gakubara cho, Anan shi, Tokushima 774 0014, Japan
    Psychiatry Res 169:178-9. 2009
  6. ncbi Brief assessment of cognition in schizophrenia: validation of the Japanese version
    Yasuhiro Kaneda
    Department of Psychiatry, Tokushima University Hospital, Tokushima, Japan
    Psychiatry Clin Neurosci 61:602-9. 2007
  7. ncbi Correlation between plasma homovanillic acid levels and the response to atypical antipsychotics in male patients with schizophrenia
    Yasuhiro Kaneda
    Department of Psychiatry, Tokushima University Hospital, 3 18 15 Kuramoto cho, Tokushima, Tokushima 770 8503, Japan
    Clin Neuropharmacol 28:262-4. 2005
  8. ncbi Relation between estradiol and negative symptoms in men with schizophrenia
    Y Kaneda
    Department of Psychiatry, Tokushima University Hospital, Japan
    J Neuropsychiatry Clin Neurosci 17:239-42. 2005
  9. ncbi Impact of a switch from typical to atypical antipsychotic drugs on quality of life and gonadal hormones in male patients with schizophrenia
    Yasuhiro Kaneda
    Department of Psychiatry, Tokushima University Hospital, Tokushima, Japan
    Neuro Endocrinol Lett 25:135-40. 2004
  10. ncbi Predictors of subjective and objective quality of life in outpatients with schizophrenia
    Ken Yamauchi
    Department of Psychiatry, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan
    Psychiatry Clin Neurosci 62:404-11. 2008

Collaborators

  • Tetsuro Ohmori
  • Tomiki Sumiyoshi
  • Kyoko Taniguchi
  • Norio Yasui-Furukori
  • Michio Suzuki
  • Zhu Li
  • J Ichikawa
  • H Y Meltzer
  • Masahito Tomotake
  • Ken Yamauchi
  • Satsuki Sumitani
  • Takahide Taniguchi
  • Yasuhito Ishimoto
  • Sawako Kinouchi
  • Shu Ichi Ueno
  • Jun Ichi Iga
  • Hirofumi Aki
  • Shusuke Numata
  • Ikuyo Motoki
  • Jun-ichi Iga
  • Shu-ichi Ueno
  • Yoshinori Ueoka
  • Shinya Tayoshi
  • Yumiko Izaki
  • Shin Ya Tayoshi
  • Takumi Ikuta
  • Sumiko Shibuya-Tayoshi
  • Sumiko Tayoshi
  • Michitaka Aono
  • Masahito Nakataki
  • Tsunehiko Tanaka
  • Syusuke Numata
  • Kazuhiko Moriguchi
  • Syu ichi Ueno
  • Yumiko Takikawa
  • Shin-Ya Tayoshi
  • Hiroshi Nakayama
  • Masato Tomotake
  • Noriko Furuta
  • Masao Okura
  • Xu Ming
  • Shouichi Kihara
  • Isao Nagamine
  • Kazunari Yamanishi
  • Junichi Iga
  • Koji Ohta
  • Naomi Kameoka
  • Mami Matsushita
  • Song Hongwei
  • Mami Tsuno
  • Hirosi Aki

Detail Information

Publications32

  1. ncbi [The Schizophrenia Cognition Rating Scale Japanese version (SCoRS-J) as a co-primary measure assessing cognitive function in schizophrenia]
    Yasuhiro Kaneda
    Department of Psychiatry, Iwaki Clinic, Tokushima, Japan
    Nihon Shinkei Seishin Yakurigaku Zasshi 31:259-62. 2011
    ..For its clinical application, we developed the Japanese-language version of the SCoRS (SCoRS-J) and UPSA (UPSA-J) through back-translation into English...
  2. ncbi Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment
    Yasuhiro Kaneda
    Department of Psychiatry, Iwaki Clinic, Anan, Tokushima, Japan
    Psychiatry Res 178:57-62. 2010
    ..Treatment that enhances cognitive function, especially verbal working memory, may lead to better employment outcomes in treatment-resistant schizophrenia or schizoaffective disorder patients...
  3. ncbi Verbal working memory and functional outcome in patients with unipolar major depressive disorder
    Yasuhiro Kaneda
    Department of Psychiatry, Iwaki Clinic, Tokushima, Japan
    World J Biol Psychiatry 10:591-4. 2009
    ..The findings in this study suggested that enhancement of verbal WM function may be useful to achieve normalization of functioning as an important component of remission in addition to symptomatic remission...
  4. ncbi Verbal working memory impairment in patients with current episode of unipolar major depressive disorder and in remission
    Yasuhiro Kaneda
    Department of Psychiatry, Iwaki Clinic, 11 1 Kamimizuta, Tokushima, Japan
    Clin Neuropharmacol 32:346-7. 2009
    ..It is suggested that WM/central executive function in MDD might be impaired, and thus verbal WM might be, at least to a degree, trait related...
  5. ncbi Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function
    Yasuhiro Kaneda
    Department of Psychiatry, Iwaki Clinic, 11 1 Kamimizuta, Gakubara cho, Anan shi, Tokushima 774 0014, Japan
    Psychiatry Res 169:178-9. 2009
    ..Among neurocognitive functions, verbal working memory (as reflected by the Consonant Trigram Test) was the strongest predictor of employment status...
  6. ncbi Brief assessment of cognition in schizophrenia: validation of the Japanese version
    Yasuhiro Kaneda
    Department of Psychiatry, Tokushima University Hospital, Tokushima, Japan
    Psychiatry Clin Neurosci 61:602-9. 2007
    ..This preliminary study indicates that the BACS-J is a reliable and practical scale to evaluate cognitive function...
  7. ncbi Correlation between plasma homovanillic acid levels and the response to atypical antipsychotics in male patients with schizophrenia
    Yasuhiro Kaneda
    Department of Psychiatry, Tokushima University Hospital, 3 18 15 Kuramoto cho, Tokushima, Tokushima 770 8503, Japan
    Clin Neuropharmacol 28:262-4. 2005
    ..The authors investigated the effects of atypical antipsychotic drugs-olanzapine, perospirone, and quetiapine-on plasma homovanillic acid (pHVA) in male patients with chronic schizophrenia...
  8. ncbi Relation between estradiol and negative symptoms in men with schizophrenia
    Y Kaneda
    Department of Psychiatry, Tokushima University Hospital, Japan
    J Neuropsychiatry Clin Neurosci 17:239-42. 2005
    ..Changes in negative symptoms were positively correlated with those in estradiol concentrations at a trend level of significance. Estradiol could be a biological marker for negative symptoms even in male schizophrenia patients...
  9. ncbi Impact of a switch from typical to atypical antipsychotic drugs on quality of life and gonadal hormones in male patients with schizophrenia
    Yasuhiro Kaneda
    Department of Psychiatry, Tokushima University Hospital, Tokushima, Japan
    Neuro Endocrinol Lett 25:135-40. 2004
    ..We investigated the effects of a switch from typical to atypical antipsychotic drugs (olanzapine, n=8; perospirone, n=9; or quetiapine, n=13) on quality of life and hypothalamo-pituitary-gonadal axis hormones...
  10. ncbi Predictors of subjective and objective quality of life in outpatients with schizophrenia
    Ken Yamauchi
    Department of Psychiatry, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan
    Psychiatry Clin Neurosci 62:404-11. 2008
    ..Particular attention was paid to cognitive function as a predictor of QOL...
  11. ncbi Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia
    Hirofumi Aki
    Department of Psychiatry, Institute of Health Biosciences, The University of Tokushima Graduate School, 3 18 15 Kuramoto cho, Tokushima, Tokushima 770 8503, Japan
    Psychiatry Res 158:19-25. 2008
    ....
  12. ncbi Subjective and objective measures of quality of life have different predictors for people with schizophrenia
    Masahito Tomotake
    Department of Psychiatry, Institute of Health Biosciences, The University of Tokushima Graduate School, 3 18 15, Kuramoto Cho, Tokushimashi, Tokushima 770 8503, Japan
    Psychol Rep 99:477-87. 2006
    ..These results suggest that subjective and objective quality of life have different predictors and should be considered as separate and complementary outcome variables...
  13. ncbi Quality of life and cognitive dysfunction in people with schizophrenia
    Yoshinori Ueoka
    Department of Psychiatry, Institute of Health Bioscience, The University of Tokushima Graduate School, Japan
    Prog Neuropsychopharmacol Biol Psychiatry 35:53-9. 2011
    ..The results suggest that negative and depressive symptoms are important factors on patients' QOL and also support the view that cognitive performance provides a determinant of QOL in patients with schizophrenia...
  14. ncbi Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms
    Takahide Taniguchi
    Department of Psychiatry, University of Tokushima School of Medicine, Tokushima City, Tokushima, Japan
    Hum Psychopharmacol 21:439-45. 2006
    ..4 +/- 4.3 mg/day) of previous drugs (n = 11). The results suggest that replacement with QTP improves symptoms as well as objective and subjective QOL in a subgroup of schizophrenia...
  15. ncbi Schizophrenia Quality of Life Scale: validation of the Japanese version
    Yasuhiro Kaneda
    Department of Neuropsychiatry, University of Tokushima School of Medicine, 3 18 15, Kuramoto Cho, Tokushima, Tokushima 770 8503, Japan
    Psychiatry Res 113:107-13. 2002
    ..There were associations with relevant SF-36, WHO QOL-26, and DIEPSS scores. From the results of the testing of the reliability and validity of the JSQLS, it is concluded that the JSQLS is a simple and reliable scale...
  16. ncbi Possible relationship between testosterone and comorbid major depressive episode in male patients with schizophrenia treated with typical antipsychotic medications
    Yasuhiro Kaneda
    Department of Neuropsychiatry, University of Tokushima School of Medicine, Tokushima, Japan
    Clin Neuropharmacol 26:291-3. 2003
    ..It is suggested that we should be aware of testosterone levels when we find depression in chronic male schizophrenia patients, especially those treated with high-dose typical antipsychotic medications...
  17. ncbi The hypothalamic-pituitary-adrenal axis in chronic schizophrenic patients long-term treated with neuroleptics
    Yasuhiro Kaneda
    Department of Neuropsychiatry, University of Tokushima School of Medicine, 3 18 15 Kuramoto cho, Tokushima 770 8503, Japan
    Prog Neuropsychopharmacol Biol Psychiatry 26:935-8. 2002
    ..The authors investigated the hypothalamic-pituitary-adrenal (HPA) axis of regularly medicated schizophrenic patients...
  18. ncbi Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms
    Shusuke Numata
    Department of Psychiatry, Course of Integrated Brain Sciences, Medical Informatics, Institute of Health Biosciences, The University of Tokushima Graduate School, 3 8 15 Kuramoto cho, Tokushima 770 8503, Japan
    Neurosci Lett 401:1-5. 2006
    ..21). Our investigation indicates that the BDNF gene Val66Met polymorphism is related to the onset age of schizophrenia and the levels of clinical symptoms that remain after long-term antipsychotic treatment...
  19. ncbi Differences in waveforms of cerebral evoked potentials among healthy subjects, schizophrenics, manic-depressives and epileptics
    Takumi Ikuta
    Department of Neuropsychiatry, The University of Tokushima School of Medicine, Tokushima, Japan
    J Med Invest 54:303-15. 2007
    ..These results might suggest the existence of a waveform for individual EPs specific to each of these diagnostic groups, for each sex...
  20. ncbi No relationship between testosterone levels and depressive symptoms in aging men
    Yasuhiro Kaneda
    Department of Neuropsychiatry, The University of Tokushima School of Medicine, Tokushima, Japan
    Eur Psychiatry 17:411-3. 2002
    ..There was no significant difference in the mean levels of the serum testosterone between the groups of patients and normals. For both groups, there was no significant correlation between testosterone and total depression scores or age...
  21. ncbi Gynecomastia with sulpiride
    Y Kaneda
    Department of Neuropsychiatry, The University of Tokushima School of Medicine, Tokushima, Japan
    J Clin Pharm Ther 27:75-7. 2002
    ....
  22. ncbi Effects of risperidone on gonadal axis hormones in schizophrenia
    Y Kaneda
    Department of Neuropsychiatry, University of Tokushima School of Medicine, Department of Neuropsychiatry, Fujii Hospital, 3 18 15 Kuramoto cho, Tokushima 770 8503, Japan
    Ann Pharmacother 35:1523-7. 2001
    ..To investigate the effects of risperidone on the hypothalamo-pituitary-gonadal (HPG) axis of chronic schizophrenic male inpatients medicated regularly...
  23. ncbi Mild serotonin syndrome on fluvoxamine
    Y Kaneda
    Department of Neuropsychiatry, University of Tokushima School of Medicine, 3 18 15 Kuramoto cho, Tokushima 770 8503, Japan
    Int J Neurosci 109:165-72. 2001
    ....
  24. ncbi Effects of tandospirone, a serotonin-1A agonist, on the hypothalamo-pituitary-gonadal axis of male patients
    Y Kaneda
    Department of Neuropsychiatry, The University of Tokushima School of Medicine, Tokushima 770 8503, Japan
    Neuro Endocrinol Lett 22:243-7. 2001
    ....
  25. ncbi Depressive symptoms in chronic schizophrenia patients: any differences between patients with and without a major depressive episode?
    Yasuhiro Kaneda
    Psychopharmacology Division, Psychiatric Hospital at Vanderbilt, 1601, 23rd Avenue South, Suite 306, Nashville, TN 37212, USA
    Eur Psychiatry 18:137-9. 2003
    ..The total depression score was correlated with the dosage of antipsychotics in patients without an MDE, but such a correlation was not found in patients with an MDE...
  26. ncbi Quetiapine impact on quality of life in patients with schizophrenia
    Yasuhiro Kaneda
    Ann Pharmacother 37:917-8. 2003
  27. ncbi Impact of risperidone medication on quality of life and gonadal axis hormones in schizophrenia male patients with acute exacerbation
    Yasuhiro Kaneda
    Psychopharmacology Division, Psychiatric Hospital at Vanderbilt, Nashville, TN 37212, USA
    Int J Neuropsychopharmacol 6:247-52. 2003
    ..Our findings suggested that risperidone might improve psychosocial and motivation/energy QoL subscales, and increase prolactin without affecting the HPG axis hormones...
  28. ncbi Effects of quetiapine on gonadal axis hormones in male patients with schizophrenia: a preliminary, open study
    Yasuhiro Kaneda
    Psychopharmacology Division, Psychiatric Hospital at Vanderbilt, 1601 23rd Avenue South, Suite 306, Nashville, TN 37212, USA
    Prog Neuropsychopharmacol Biol Psychiatry 27:875-8. 2003
    ..The authors investigated the effects of a novel antipsychotic agent, quetiapine administration on hypothalamo-pituitary-gonadal (HPG) axis hormones in patients with chronic schizophrenia...
  29. ncbi The impact of prolactin elevation with antipsychotic medications on subjective quality of life in patients with schizophrenia
    Yasuhiro Kaneda
    Psychopharmacology Division, Psychiatric Hospital at Vanderbilt, 1601 23rd Avenue South, Suite 306, Nashville, TN 37212, USA
    Clin Neuropharmacol 26:182-4. 2003
    ..475), and dose of antipsychotics and BPRS anergia factor in the symptoms/side effects subscale (adjusted R2 = 0.206). The results did not support the hypothesis...
  30. ncbi Repetitive behaviors in chronic schizophrenia: using the Japanese version of the Elgin Behavior Rating Scale (JEBRS)
    Yasuhiro Kaneda
    Psychopharmacology Division, Psychiatric Hospital at Vanderbilt, Nashville, Tennessee 37212, USA
    Int J Neurosci 113:879-90. 2003
    ..The total score for nine repetitive behaviors in the JEBRS was positively correlated with positive and negative symptoms. This study showed that the JEBRS is a useful and reliable scale...
  31. ncbi Suicidality in schizophrenia as a separate symptom domain that may be independent of depression or psychosis
    Yasuhiro Kaneda
    Schizophr Res 81:113-4. 2006
  32. ncbi Serotonin receptors: their key role in drugs to treat schizophrenia
    Herbert Y Meltzer
    Department of Psychiatry, Division of Psychopharmacology, Vanderbilt University School of Medicine, Suite 306, 1601 23rd Avenue, Nashville, TN 37212, USA
    Prog Neuropsychopharmacol Biol Psychiatry 27:1159-72. 2003
    ..g., the D3 or D4 receptor, and drugs that are selective for them...